专利检索 ap:("Alnylam Pharmaceuticals, Inc.") AND inv:"ERBE, David" 第 1 页

1.

发明公开
METHODS AND COMPOSITIONS FOR TREATING SUBJECTS HAVING OR AT RISK OF DEVELOPING A NON-PRIMARY HYPEROXALURIA DISEASE OR DISORDER 审中-实审

公开(公告)号：EP4373934A1

公开(公告)日：2024-05-29

申请号：EP22754232.1

申请日：2022-07-18

申请人： Alnylam Pharmaceuticals, Inc.

发明人： GANSNER, John, M. , ERBE, David

IPC分类号： C12N15/113 , A61K31/713

CPC分类号： C12N15/1137 , C12N2310/1420130101 , C12N2320/3520130101 , C12N2320/3120130101 , C12N2310/35120130101 , C12N2310/31520130101 , C12N2310/34420130101 , C12Y101/03015 , C12Y105/05 , C12Y101/01027

2.

发明公开
COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING STARGARDT'S DISEASE AND/OR RETINAL BINDING PROTEIN 4 (RBP4)-ASSOCIATED DISORDERS 审中-实审

公开(公告)号：EP4351541A2

公开(公告)日：2024-04-17

申请号：EP22738118.3

申请日：2022-06-03

申请人： Alnylam Pharmaceuticals, Inc.

发明人： FITZGERALD, Kevin , ERBE, David , ZUBER, Jeffrey , TICAU, Simina , GOLLOB, Jared, A.

IPC分类号： A61K31/00 , A61P27/02

CPC分类号： A61K31/00 , A61P27/02

3.

发明公开
PROLINE DEHYDROGENASE 2 (PRODH2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF 审中-公开

公开(公告)号：EP4314293A1

公开(公告)日：2024-02-07

申请号：EP22716652.7

申请日：2022-03-24

申请人： Alnylam Pharmaceuticals, Inc.

发明人： ERBE, David , MCININCH, James, D.

IPC分类号： C12N15/113 , A61K31/713

4.

发明公开
COMPOSITIONS AND METHODS FOR TREATING SUBJECTS HAVING A HETEROZYGOUS ALANINE-GLYOXYLATE AMINOTRANSFERASE GENE (AGXT) VARIANT 审中-公开

公开(公告)号：EP4121534A1

公开(公告)日：2023-01-25

申请号：EP21717697.3

申请日：2021-03-17

申请人： Alnylam Pharmaceuticals, Inc.

发明人： DEATON, Aimee, M. , ERBE, David

IPC分类号： C12N15/113